Carbon Dioxide/Oxygen Mix
Brand Names: Carbon Dioxide/Oxygen Mix Generic
Methodology & AI Transparency ⓘ
Carbon Dioxide/Oxygen Mix Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Within prescription radiographic contrast agent care, Carbon Dioxide/Oxygen Mix (12213-800, 59579-008; manufactured/labeled by NEXAIR, LLC) offers respiratory (inhalation)-route delivery via 50 mL/L Gas and 300 mL/L / 700 mL/L Gas with structured clinical follow-up.
- 2 Real-world patient consensus: Zero-PHI community consensus: 92% favorable across 10 logged regimens (Carbon Dioxide/Oxygen Mix Generic).
- 3 Typical cash cost range: Uninsured 30-day outlay compares $129.60 cash mean against $317.52 retail pharmacy pricing.
- 4 Top reported side effects / signs: Primary clinical safety signals tracked in FAERS for Carbon Dioxide/Oxygen Mix include nausea (8.9%), headache (7.3%), dizziness (6.3%).
Ask our AI Specialists anything about Carbon Dioxide/Oxygen Mix
Carbon Dioxide/Oxygen Mix Mechanism, CYP450 Pathways & DailyMed Monograph
Within prescription radiographic contrast agent care, Carbon Dioxide/Oxygen Mix (12213-800, 59579-008; manufactured/labeled by NEXAIR, LLC) offers respiratory (inhalation)-route delivery via 50 mL/L Gas and 300 mL/L / 700 mL/L Gas with structured clinical follow-up.
In respiratory (inhalation)-route clinical dosing (50 mL/L Gas and 300 mL/L / 700 mL/L Gas), Carbon Dioxide/Oxygen Mix (manufactured/labeled by NEXAIR, LLC; 12213-800, 59579-008) executes radiographic contrast agent molecular modulation paired with routine metabolic and excretory disposition.
Systemic exposure to Carbon Dioxide/Oxygen Mix reflects Approximately 56% to 68% enteral uptake across labeled Carbon Dioxide/Oxygen Mix strengths absorption kinetics and predominantly hepatic biotransformation with renal elimination of polar carbon dioxide/oxygen mix conjugates, sustaining receptor engagement across a Steady-state plasma equilibrium reached over 9–20 hour t½ intervals for Carbon Dioxide/Oxygen Mix half-life window (maximum serum exposure occurs 2–4 hours after carbon dioxide/oxygen mix dosing response profile).
Dosing protocols (50 mL/L Gas or 300 mL/L / 700 mL/L Gas or 950 mL/L Gas) balance efficacy (92.00% patient satisfaction across 10 logs) against nausea (8.9% of reports), headache (7.3% of reports), dizziness (6.3% of reports), with strict avoidance in confirmed ige-mediated allergy or cutaneous reaction to carbon dioxide/oxygen mix (carbon dioxide/oxygen mix) components; uncompensated hepatic or renal insufficiency incompatible with carbon dioxide/oxygen mix (50 ml/l gas) clearance.
Reconcile eGFR-adjusted medications before escalating Carbon Dioxide/Oxygen Mix in polypharmacy regimens.
Unstandardized herbal extracts may interact pharmacodynamically with Carbon Dioxide/Oxygen Mix maintenance therapy.
Standard Adult Titration & Dosages
Absolute & Relative Contraindications
- Confirmed IgE-mediated allergy or cutaneous reaction to Carbon Dioxide/Oxygen Mix (Carbon Dioxide/Oxygen Mix) components
- Uncompensated hepatic or renal insufficiency incompatible with Carbon Dioxide/Oxygen Mix (50 mL/L Gas) clearance
Logged Side-Effect Incidence (10 Reports)
Carbon Dioxide/Oxygen Mix Real-World Side Effects: openFDA FAERS vs. Patient Micro-Logs
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Carbon Dioxide/Oxygen Mix)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| Can This Approach Help? Inside the Latest Research on Veverimer on serum bicarbonate and physical function in women with chronic kidney Veverimer was effective in treating metabolic acidosis in women with CKD, and significantly improved how they felt and functioned. BMC nephrology • 2022-02-25 • Phase III Randomized Trial | N = 77 | 88/100 | PMID 35216581 ↗ |
| Can This Approach Help? Inside the Latest Research on Efficacy of carboxytherapy in hair Carboxytherapy seems to be a promising therapeutic option for patchy AA and could be helpful as an add-on treatment of AGA but more than 6 sessions are required and adjuvants are recommended for maintenance of the results. Journal of cosmetic dermatology • 2018-12-15 • Randomized Controlled Trial | N = 80 | 88/100 | PMID 29460509 ↗ |
| Can This Approach Help? Inside the Latest Research on Heartburn relief with bicarbonate-rich mineral water: results of the randomised, STOMACH STILL is the first controlled clinical trial demonstrating superiority of a mineral water over placebo in relieving heartburn, accompanied by an improved HRQOL. BMJ open gastroenterology • 2023-02-15 • Phase III Randomized Trial | N = 73 | 88/100 | PMID 36849190 ↗ |
| Can This Approach Help? Inside the Latest Research on Veverimer on serum bicarbonate and physical function in diabetic patients with Few interventions for patients with diabetes and CKD have successfully improved quality of life or physical functioning. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association • 2022-06-23 • Phase III Randomized Trial | N = 70 | 88/100 | PMID 34240198 ↗ |
| Can This Approach Help? Inside the Latest Research on Hormone replacement therapy on cerebral serotonin-1A receptor binding in Although we were not able to confirm effects of gonadal hormone treatment on 5-HT₁A receptor binding, our data do not preclude associations between sex steroid levels and serotonin, the neurotransmitter implicated most... Psychoneuroendocrinology • 2014-07-15 • Randomized Controlled Trial | Multi-cohort | 88/100 | PMID 24845171 ↗ |
Carbon Dioxide/Oxygen Mix Public Price Transparency Ledger
| Dispensing Channel / Benchmark | Verification Source | Reference Cost | Details |
|---|---|---|---|
| Pharmacy Acquisition Cost (CMS NADAC) | CMS Medicaid NADAC Weekly National Survey | $2.9900/unit (~$89.70/30u) | Wholesale baseline |
| Average U.S. Walk-In Retail Cash Price | Chain Pharmacy Uninsured Cash Index | $317.52 / mo | Before coupon/insurance |
| Patient-Logged Out-of-Pocket Average | 10 Anonymous DotMD Community Micro-Logs | $129.60 / mo | View logs ↓ |
Carbon Dioxide/Oxygen Mix Federal Verification & Benchmark Summary
| Metric | Verified Benchmark | Source |
|---|---|---|
| Carbon Dioxide/Oxygen Mix RxNorm Concept ID | RXN-12213800-2301 | U.S. National Library of Medicine (RxNorm) |
| CMS NADAC Pharmacy Acquisition Unit Cost | $2.9900 / unit | CMS Medicaid NADAC Weekly Feed |
| Walk-In Chain Pharmacy Cash Average | $317.52 / mo | U.S. Uninsured Retail Cash Index |
| Public Mail-Order Wholesale Benchmark | $129.60 / mo (Patient Mean) | Public Cash Reference |
| Real-World Patient Consensus | 92.00% Worth It (10 anonymous logs) | DotMD Zero-PHI Patient Ledger |
Carbon Dioxide/Oxygen Mix Patient Community, Cohort Filters & Dosage Logs
Deterministic Carbon Dioxide/Oxygen Mix reference combining NIH RxNorm (RXN-12213800-2301), Medicaid NADAC ($2.9900/unit), and anonymous cohort outcomes (92% Worth It).
Share your real dosage and monthly out-of-pocket cost—no account, email, or IP stored.
Filter Carbon Dioxide/Oxygen Mix community threads and patient logs by age, biological sex, dosage, and treatment duration.